Healthcare Services Company for Sale in Mumbai, India
| Established | 5-10 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 800 - 900 thousand |
| Run Rate Sales | USD 940 thousand |
| EBITDA Margin | 20 - 30 % |
| Industries | Healthcare Services |
| Locations | Mumbai |
| Local Time | 2:35 AM Asia / Kolkata |
| Listed By | Management Member |
| Status | Active |
• Serving 50+ pharmaceutical clients, with the top 10 — predominantly listed Indian pharma majors and multinational subsidiaries — contributing approximately 80% of revenue.
• 85% client repeat rate; approximately 60% of revenue recurs through multi-programme annual engagements rather than one-off projects.
• Debt-free balance sheet with approximately INR 4.0 crore in cash and quoted investments, and net worth of approximately INR 5.7 crore as at 31 March 2026.
• Negligible credit risk: all revenue is contracted against purchase orders from large, predominantly listed pharmaceutical companies. No material bad-debt history.
• One of very few Indian firms holding registered media accreditation at more than 50 international medical congresses annually, enabling on-site scientific coverage competitors cannot replicate.
• Exclusive India collaboration with the Leicester Diabetes Centre (LDC) and with D&CVD, the educational arm of the European Association for the Study of Diabetes (EASD), for physician clinic certification.
• Accredited collaborations across cardiology, heart failure, hypertension, diabetes and gynaecology, and with the Rome Foundation in gastroenterology.
• Preferred partner for national consensus documents, delivered in association with 21 national medical societies.
• Engaged network of 300+ key opinion leaders, including 100+ international and 50+ Indian faculty across cardiology, endocrinology, gastroenterology, gynaecology and urology.
• 6,000 clinic activations completed across India; over 3,000 physician memberships and fellowships facilitated.
• Proprietary 'Expert AI' platform — a first-of-its-kind medical AI assistant converting global expert knowledge into an interactive system deployed to physicians via medical representatives.
• Recognised at IDF 2025 Bangkok for excellence in medical communications and CME. Winner, IHW Excellence Award for Service Providers, Pharmaceutical Sector (2024) and IHW Silver Award (2020). Three Indian and two international business awards in total.
• Lean, profitable structure: 10 full-time employees, 2 working directors, 2 part-time staff, plus a variable freelance scientific writing pool.
• Promoters bring over 50 years of combined experience in Indian medico-marketing.
• International conference coverage — on-site scientific reporting from global congresses under registered media accreditation, converted into India-relevant brand assets.
• Consensus documents and clinical guidelines — evidence-based national guideline development with Indian medical societies.
• Accredited certification courses — module-based physician certification written and reviewed by international faculty, accredited by globally reputed societies.
• Clinic certification programmes — diabetes clinic certification under LDC and EASD D&CVD endorsement.
• Expert-led webinars, KOL engagement and speaker tours — including in-clinic CME series delivering global KOL video content to Indian physicians via field teams.
-
6 hours agoPartner, Holding Company, Mumbai, Corporate Investor / Buyer connected with the Business
-
9 hours agoCompany Secretary, Events And Exhibition, Mumbai, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysFounder, Diagnostic Centres, Mumbai, Corporate Investor / Buyer connected with the Business